Trial intelligence / Profile preview

Strontium Ranelate for Bone Recovery in Primary Hyperparathyroidism

NCT01222026Phase 4Completed

Sponsor
Medical University of Vienna
Start
Sep 2010
Primary completion
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of strontium ranelate in osteopenia, osteoporosis, sponsored by Medical University of Vienna. Started Sep 2010; status: completed.

02

Drugs

strontium ranelate
03

Conditions

osteopeniaosteoporosis

Beyond the preview

Go deeper on NCT01222026.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01222026.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call